Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and resources, however, and countries often begin by demanding evidence (including local CEA evidence as well as evidence about local values), whilst striving to strengthen the governance structures and technical capacities with which to generate, consider and act on such evidence. In low- and middle-income countries (LMICs), such capacities could be developed initially around a small technical unit in the health ministry or health insurer. The role of networks, development partners, and global norm setting organisations is crucial in supporting the necessary capacities.
CGD Policy Blogs
- (-) Remove Technology and Development filter Technology and Development
- (-) Remove Amanda Glassman filter Amanda Glassman
- (-) Remove 2017 filter 2017
- (-) Remove Corruption, Transparency, and Governance filter Corruption, Transparency, and Governance
- (-) Remove Health Technology Assessment filter Health Technology Assessment
March 22, 2017